改变血友病TM

改变血友病是诺和诺德对血友病治疗中未被满足的需求所做出的承诺,它不仅仅是提供药品。  

血友病是一种严重的罕见病

血友病是一种严重的罕见病,世界各地大约每1万人中有1人罹患此症。许多血友病患者仍然未被诊断或未得到充分治疗。即使得到了治疗,他们也有可能因关节出血而承受长期疼痛,活动受限;当治疗不足或根本无法得到治疗时,他们则有可能在很小就失去生命。

改变血友病是诺和诺德对血友病治疗中的未被满足的需求所做出的承诺。我们致力于在未来让每一位血友病患者都得到确诊,并尽可能减少疾病对其生活的束缚。
 

改变血友病,我们的重点领域包括:

  • 科研
  • 认知及治疗可及度
  • 关节结局
 

 

Changing Haemophilia is Novo Nordisk's commitment to address the unmet needs in haemophilia care, beyond medicine

Haemophilia is a rare and serious disease

Haemophilia is a rare and serious disease affecting approx. 1 out of 10,000 people around the world. Many people with haemophilia are still undiagnosed or inadequately treated. Even when treated, people may suffer from chronic pain and limited mobility mainly due to bleeds in the joints, and if undertreated or not treated at all, risk dying at a young age.

Driving change in haemophilia 

Since Novo Nordisk was founded more than 90 years ago, we have been driving change to defeat chronic conditions. This includes three decades of improving lives of people with haemophilia through support to improved diagnosis, treatment and care.

Our key contribution 

Our key contribution is to discover and develop effective and safe medicines for people with haemophilia and other rare bleeding disorders. We offer a broad and innovative range of products and have a rich research/development pipeline to ensure we are in the forefront of finding the next generation of medicines.

Addressing unmet needs beyond medicine 

But to truly change haemophilia, we need to do more than supply the right medicines. With our Changing Haemophilia™ commitment we aim to address the unmet needs in haemophilia. Together with our community partners, we work to advocate for, and create better access to, diagnosis and multidisciplinary care. We aim for better joint health and mobility including a strong focus on well-being for people living with haemophilia.

We work towards a future where everyone with Haemophilia is diagnosed. and can live a life with as few limitations as possible.

Our three focus areas are:

•  Science. Find out more

•  Awareness and access to care. Find out more

•  Joint outcomes. Find out more


诺和诺德血友病研发

我们的主要贡献

我们的主要贡献在于为血友病及其它罕见出血性疾病患者发现并研发安全有效的药品。我们提供广泛的创新产品,并拥有丰富的研发产品线,以确保我们处于发现新一代治疗手段的最前沿。

血友病科研


诺和诺德改变血友病,治疗可及度,墨西哥

关注药品之外的未被满足的需求

但要真正改变血友病,我们要做的却不仅仅是提供好的药品。通过改变血友病这一承诺,诺和诺德致力于应对血友病领域未被满足的需求。我们与该领域的合作伙伴携手,倡导诊断与多学科治疗,并为创造更高的可及度而努力。我们致力于帮助血友病患者实现更好的关节健康及活动能力,并重点关注患者的生活质量。我们要努力让每一位血友病患者未来都能得到确诊,并尽可能减少疾病对其生活的束缚。


诺和诺德血友病基金会

诺和诺德血友病基金会

诺和诺德血友病基金会(NNHF)通过与地区及国际血友病群体成员合作,使改变成为现实。NNHF为造福血友病及相关出血性疾病患者而工作,目标是为其改善治疗可及度、治疗水平和生活质量。据估计,全球75%的患者生活在发展中国家,那里仍然缺少适当的诊断与治疗,因此他们也是我们共同关注的焦点。

诺和诺德血友病基金会


诺和诺德改变血友病